Creative Planning
KURA icon

Creative Planning’s Kura Oncology KURA Stock Holding History

Creative Planning’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.55M Buy
232,429
+30,733
+15% +$290K ﹤0.01% 1897
2026
Q1 		$1.64M Buy
201,696
+2,911
+1% +$25K ﹤0.01% 2067
2025
Q4 		$2.07M Buy
198,785
+21,730
+12% +$228K ﹤0.01% 1708
2025
Q3 		$1.57M Buy
177,055
+40,796
+30% +$291K ﹤0.01% 1742
2025
Q2 		$786K Buy
136,259
+68,959
+102% +$422K ﹤0.01% 2063
2025
Q1 		$444K Buy
67,300
+33,134
+97% +$258K ﹤0.01% 2391
2024
Q4 		$298K Buy
+34,166
New +$492K ﹤0.01% 2672

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Creative Planning's KURA Position: Q2 2026 in Review

Creative Planning increased its Kura Oncology (KURA) stake by 15% in Q2 2026, buying an estimated $290K and bringing the position to 232,429 shares worth $2.55M. The position accounts for ﹤0.01% of the portfolio, ranked #1897.

Creative Planning first reported a position in KURA in Q4 2024 and has held it in 7 quarters since. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Creative Planning held 232,429 shares of Kura Oncology worth $2.55M as of Q2 2026.
  • Creative Planning bought 30,733 Kura Oncology shares in Q2 2026, an estimated $290K.
  • Kura Oncology made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #1897 holding.
  • Creative Planning first reported a position in Kura Oncology in Q4 2024 and has held it in 7 quarters since.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.